AbCellera Biologics Inc. ABCL Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$146.41M+10.1% | -$162.86M-11.2% | -$146.4M— | —— | ||
| $18.39M+47.7% | $12.46M-3.0% | $12.84M+43.8% | $8.93M+99.2% | ||
| $55.79M-17.4% | $67.58M+5.3% | $64.18M+29.7% | $49.48M+61.5% | ||
| -$131.3M-20.9% | -$108.56M— | —— | —— | ||
| $42.77M-45.4% | $78.4M+1.9% | $76.95M+8.9% | $70.66M+20.9% | ||
| $87.75M-27.7% | $121.41M+155% | -$221.11M+37.3% | -$352.63M-6.1% | ||
| —— | $12.77M+23.3% | $10.36M— | —— | ||
| —— | $23.01M+109% | -$254.04M— | —— | ||
| -$174.07M+6.9% | -$186.95M-54.7% | -$120.82M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does AbCellera Biologics Inc.'s cash flow data come from?
- Every line is extracted from AbCellera Biologics Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.